Процеси ліпопероксидації у хворих на серцеву недостатність

Автор(и)

  • О. Гулага
  • В. Тащук
  • О. Полянська

Ключові слова:

процеси ліпопероксидації; серцева недостатність

Анотація

У статті наведено дані літератури про роль процесів пероксидного окиснення ліпідів та антиоксидантного захисту у хворих на серцеву недостатність.

Посилання

Byshevskiy ASh, Umutbaeva MK, Alborov RG. Postoyannoe vnutrisosudistoe svertyvanie krovi pri izmenenii intensivnosti lipoperoksidatsii [Constant intravascular coagulation with a change in the intensity of lipid peroxidation]. Biomeditsinskaya khimiya. 2005;51(4):424-31. (in Russian).

Volkov VI, Bodnar' TN, Yakovleva LN. Vliyanie statinov na syrovatochnoe soderzhanie C-reaktivnogo belka i matrichnoy metalloproteinazy-9 pri ostrom koronarnom sindrome bez pod'ema segmenta ST [The effect of statins on the serum content of C-reactive protein and matrix metalloproteinase-9 in acute coronary syndrome without ST segment elevation]. Sertse i sudyny. 2007;2:59-64. (in Russian).

Vorontsova NL, Berns SA, Barabash OL. Svobodnoradikal'noe okislenie i miokard [Free radical oxidation and myocardium]. Moscow: Kemerovo; 2006. 159 p. (in Russian).

Zheltukhina ME. Vliyanie mezoentsefal'noy modulyatsii na perekisnoe okislenie lipidov pri ostrom koronarnom sindrome [The effect of mesoencephalic modulation on lipid peroxidation in acute coronary syndrome]. Vestnik novykh meditsinskikh tekhnologiy. 2007;14(1):82. (in Russian).

Zmushko EI, Belozerov ES, Mitin Yu. Klinicheskaya immunologiya [Clinical Immunology]. St. Petersburg: Piter; 2001. 576 p. (in Russian).

Barbarash LS, Kashtalap VV, Karetnikova VN. Klinicheskaya znachimost' pokazateley endotelial'noy disfunktsii, oksidativnogo stressa i gemostaza u bol'nykh infarktom miokarda [The clinical significance of endothelial dysfunction, oxidative stress and hemostasis in patients with myocardial infarction]. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2007;2:28-33. (in Russian).

Kovalenko VM. Ateroskleroz i asotsiiovani z nym khvoroby vnutrishnikh orhaniv: zahal'na stratehiia profilaktyky ta etapnist' spetsializovanoho likuvannia [Atherosclerosis and associated diseases of the internal organs: the general strategy of prevention and stages of specialized treatment]. Ukrains'kyi kardiolohichnyi zhurnal. 2007;5:8-11. (in Ukrainian).

Lutay MI. Ateroskleroz i sovremennyy vzglyad na patogenez [Atherosclerosis and a modern view of pathogenesis]. Ukrains'kyi kardiolohichnyi zhurnal. 2004;1:22-4. (in Russian).

Malaya LT, Gorb YuG. Khronicheskaya serdechnaya nedostatochnost': dostizheniya, problemy, perspektivy [Chronic heart failure: achievements, problems, prospects]. Kharkov: Torsing; 2002. 768 p. (in Russian).

Mishchenko IV. Rol' sosudistoy stenki v reaktsiyakh perekisnogo okisleniya lipidov i gemostaza pri dozirovannoy fizicheskoy nagruzke u bol'nykh gipertonicheskoy bolezn'yu [The role of the vascular wall in the reactions of lipid peroxidation and hemostasis during dosed physical activity in patients with hypertension]. Eksperymental'na i klinichna medytsyna. 2001;1:69-71. (in Russian).

Shumakov VO, Bratus' VV, Tolaieva TV. Protyzapal'na diia symvastatynu u khvorykh z hostrym infarktom miokarda [Anti-inflammatory effect of simvastatin in patients with acute myocardial infarction]. Ukrains'kyi kardiolohichnyi zhurnal. 2002;5:33-7. (in Ukrainian).

Trifonov IR. Effektivnost' blokatora retseptorov k al'dosteronu eplerenona u bol'nykh s ostrym infarktom miokarda s priznakami serdechnoy nedostatochnosti: rezul'taty issledovaniya EPHESUS [Efficiency of eplerenone aldosterone receptor blocker in patients with acute myocardial infarction with signs of heart failure: EPHESUS study results]. Kardiologiya. 2003;6:71-2. (in Russian).

Shevchenko OS. Perekysne okysnennia lipidiv ta bilkiv klityn u formuvanni kal'tsiiezalezhnoho poshkodzhennia miokarda na etapakh dekompensatsii khronichnoi sertsevoi nedostatnosti [Peroxidation of lipids and cell proteins in the formation of calcium-dependent myocardial damage in the stages of decompensation of chronic heart failure]. Medychna khimiia. 2005;7(2):31-5. (in Ukrainian).

Agostoni P, Magini A, Andreini D, Contini M, Apostolo A, Bussotti M, et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J. 2005;26(2):159-64.

Bauersachs J, Fraccarollo D. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Minerva Cardioangiol. 2003;51(2):155-64.

##submission.downloads##

Опубліковано

2021-12-20

Номер

Розділ

ТЕОРЕТИЧНА МЕДИЦИНА